Rush Pharmacy
- 503A
“All TeleClinic prescriptions are filled by Rush Pharmacy, a licensed 503A compounding pharmacy authorized under Section 503A of the Federal Food, Drug, and Cosmetic Act.”
Source: tele.clinic · Verified 2026-07-16

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8/10
Best for: knowing which pharmacy fills the vial — it names Rush Pharmacy
TeleClinic's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Cash pays for everything; insurance is absent. Monthly rates are flat, shipping is free, and 47 states are covered. Rush Pharmacy fills the prescriptions, a 503A compounder the company calls PCAB-accredited. Injections of B12/MIC and NAD+ are also on offer from Teleclinic Holdings LLC, whose compounded tirzepatide and semaglutide are prescribed by physicians. LegitScript certifies it. Neither compounded drug carries FDA approval.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Six columns, each one computed from something TeleClinic has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
$199/month is 5% above the register median of $189 for compounded semaglutide.
Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
On the seller's own pages, a price is published before the questionnaire starts.
names its dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is high.
Publishes coverage in 47 of 50 states.
The price covers medication, consult, shipping.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Prices re-verified
Ongoing month-to-month; first-quarter intro $139/mo billed quarterly
Ongoing month-to-month; first-quarter intro $219/mo billed quarterly
Check the price yourself before you pay
Every figure here was read off TeleClinic's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Each partner below is a 503A or 503B pharmacy that TeleClinic routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
“All TeleClinic prescriptions are filled by Rush Pharmacy, a licensed 503A compounding pharmacy authorized under Section 503A of the Federal Food, Drug, and Cosmetic Act.”
Source: tele.clinic · Verified 2026-07-16
The standing price at TeleClinic is $199/month. That sits above the middle of the market, which puts the burden on whatever else is in the package.
The median standing price across the GLP-1 providers we track is about $169/month, so this is a premium, and a premium has to buy something. Check what is bundled before accepting it.
Found dispenses semaglutide and tirzepatide from $149/month, which makes it the honest comparison to run before committing here.
TeleClinic prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.
On the record: it treats patients in all 50 states, it dispenses through an accredited compounding pharmacy, and it names the pharmacy that fills its prescriptions. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
TeleClinic costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. Breeze Meds is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
TeleClinic's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Starting at $199/month. Check today's price, then book the free consultation.
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
The words sellers use, defined. Tap any term.
Cited across this TeleClinic review: primary regulatory filings, and peer-reviewed studies.
Plans start at $199/month. The free consultation is where you learn whether you qualify, and what it costs today.